Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/00000441-195604000-00004 | DOI Listing |
bioRxiv
November 2024
Section of Nephrology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.
Common intronic enhancer SNPs in Shroom3 associate with CKD in GWAS, although there is paucity of detailed mechanism. Previously, we reported a role for Shroom3 in mediating crosstalk between TGFβ1- & Wnt/Ctnnb1 pathways promoting renal fibrosis (TIF). However, beneficial roles for Shroom3 in proteinuria have also been reported suggesting pleiotropic effects.
View Article and Find Full Text PDFJ Vet Intern Med
December 2024
Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine, Chungbuk National University, Cheongju, 28644, Republic of Korea.
BMC Vet Res
October 2024
Faculty of Veterinary Medicine, Department of Internal Medicine, Selcuk University, Konya, 42250, Türkiye.
Background: Mitochondrial biogenesis (MB) induction has recently emerged as potential therapeutic approaches in kidney pathology and the mitochondria-targeted therapies should be investigated to improve treatment of animals with kidney diseases. This study aimed to investigate the effects of MB induction with sildenafil citrate on the cGMP/NO pathway, glomerular filtration, and reduction of kidney damage and fibrosis (TGF-β/SMAD pathway) in cats with acute on chronic kidney disease (ACKD). Thirty-three cats were divided into the non-azotemic (healthy) group (n:8) and the ACKD group (n:25), comprising different breeds, sexes, and ages.
View Article and Find Full Text PDFAnimals (Basel)
September 2024
Clinic for Small Animals (Internal Medicine, Clinical Pathology and Clinical Pathophysiology), Justus-Liebig University of Giessen, 35392 Giessen, Germany.
Nutrients
July 2024
Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!